REVVITY, INC APIC, Share-based Payment Arrangement, Increase for Cost Recognition
REVVITY, INC (RVTY) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $2.79 million for the 3-month period ending 2026-07-05, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-11
- REVVITY, INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-07-05 was $2.79M, a 22.81% increase year-over-year.
- REVVITY, INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-04-05 was $2.89M, a 38.10% increase year-over-year.
- REVVITY, INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-28 was $2.35M, a 11.08% decline year-over-year.
- REVVITY, INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-29 was $2.27M, a 7.94% decline year-over-year.
- REVVITY, INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $9.18M, a 5.45% decline from fiscal 2024.
- REVVITY, INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $9.71M, a 7.51% decline from fiscal 2023.
- REVVITY, INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $10.50M, a 1.11% increase from fiscal 2023.
- REVVITY, INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $10.38M, a 66.10% increase from fiscal 2022.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-07-05 | $2.79M 10-Q · filed 2026-08-11 | $5.68M derived: sum of 2 quarters · filed 2026-08-11 | ||
| 2026-04-05 | $2.89M 10-Q · filed 2026-08-11 | |||
| 2025-12-28 | $9.18M 10-K · filed 2026-02-24 | |||
| 2025-09-28 | $2.35M 10-Q · filed 2025-11-04 | $4.62M derived: sum of 2 quarters · filed 2026-08-11 | $6.71M derived: sum of 3 quarters · filed 2026-08-11 | |
| 2025-06-29 | $2.27M 10-Q · filed 2026-08-11 | $4.36M derived: sum of 2 quarters · filed 2026-08-11 | ||
| 2025-03-30 | $2.09M 10-Q · filed 2026-08-11 | |||
| 2024-12-29 | $9.71M 10-K · filed 2026-02-24 | |||
| 2024-09-29 | $2.65M 10-Q · filed 2025-11-04 | $5.11M derived: sum of 2 quarters · filed 2025-11-04 | $7.67M derived: sum of 3 quarters · filed 2025-11-04 | |
| 2024-06-30 | $2.47M 10-Q · filed 2025-11-04 | $5.03M derived: sum of 2 quarters · filed 2025-11-04 | ||
| 2024-03-31 | $2.56M 10-Q · filed 2025-11-04 | |||
| 2023-12-31 | $10.50M 10-K · filed 2026-02-24 | |||
| 2023-10-01 | $2.51M 10-Q · filed 2024-11-06 | $5.39M derived: sum of 2 quarters · filed 2024-11-06 | $8.43M derived: sum of 3 quarters · filed 2024-11-06 | |
| 2023-07-02 | $2.89M 10-Q · filed 2024-11-06 | $5.92M derived: sum of 2 quarters · filed 2024-11-06 | ||
| 2023-04-02 | $3.03M 10-Q · filed 2024-11-06 | |||
| 2023-01-01 | $10.38M 10-K · filed 2025-02-25 | |||
| 2022-10-02 | $1.94M 10-Q · filed 2023-11-07 | $5.70M derived: sum of 2 quarters · filed 2023-11-07 | $8.49M derived: sum of 3 quarters · filed 2023-11-07 | |
| 2022-07-03 | $3.76M 10-Q · filed 2023-11-07 | $6.55M derived: sum of 2 quarters · filed 2023-11-07 | ||
| 2022-04-03 | $2.79M 10-Q · filed 2023-11-07 | |||
| 2022-01-02 | $6.25M 10-K · filed 2024-02-27 | |||
| 2021-10-03 | $1.48M 10-Q · filed 2022-11-14 | $3.44M derived: sum of 2 quarters · filed 2022-11-14 | $4.34M derived: sum of 3 quarters · filed 2022-11-14 | |
| 2021-07-04 | $1.96M 10-Q · filed 2022-11-14 | $2.86M derived: sum of 2 quarters · filed 2022-11-14 | ||
| 2021-04-04 | $899.00K 10-Q · filed 2022-11-14 | |||
| 2021-01-03 | $3.66M 10-K · filed 2023-03-01 | |||
| 2020-10-04 | $947.00K 10-Q · filed 2021-11-09 | $2.58M derived: sum of 2 quarters · filed 2021-11-09 | $3.58M derived: sum of 3 quarters · filed 2021-11-09 | |
| 2020-07-05 | $1.63M 10-Q · filed 2021-11-09 | $2.63M derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-04-05 | $997.00K 10-Q · filed 2021-11-09 | |||
| 2019-12-29 | $6.63M 10-K · filed 2022-03-03 | |||
| 2019-09-29 | $3.09M 10-Q · filed 2020-11-10 | $4.39M derived: sum of 2 quarters · filed 2020-11-10 | $5.76M derived: sum of 3 quarters · filed 2020-11-10 | |
| 2019-06-30 | $1.30M 10-Q · filed 2020-11-10 | $2.67M derived: sum of 2 quarters · filed 2020-11-10 | ||
| 2019-03-31 | $1.37M 10-Q · filed 2020-11-10 | |||
| 2018-12-30 | $5.38M 10-K · filed 2021-03-02 | |||
| 2018-09-30 | $1.46M 10-Q · filed 2019-11-05 | $2.80M derived: sum of 2 quarters · filed 2019-11-05 | $4.04M derived: sum of 3 quarters · filed 2019-11-05 | |
| 2018-07-01 | $1.34M 10-Q · filed 2019-11-05 | $2.58M derived: sum of 2 quarters · filed 2019-11-05 | ||
| 2018-04-01 | $1.24M 10-Q · filed 2019-11-05 | |||
| 2017-12-31 | $4.99M 10-K · filed 2020-02-25 | |||
| 2017-01-01 | $4.63M 10-K · filed 2019-02-26 | |||
| 2016-01-03 | $4.30M 10-K · filed 2018-02-27 | |||
| 2014-12-28 | $4.88M 10-K · filed 2017-02-28 | |||
| 2013-12-29 | $4.45M 10-K · filed 2016-03-01 | |||
| 2012-12-30 | $5.02M 10-K · filed 2015-02-24 | |||
| 2012-01-01 | $4.54M 10-K · filed 2014-02-25 | |||
| 2011-01-02 | $6.50M 10-K · filed 2013-02-26 | |||
| 2010-01-03 | $8.58M 10-K · filed 2012-02-28 | |||
| 2008-12-28 | $10.56M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |